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Abstract
There is evidence that anaemia is associated with aluminium (Al). We have already reported on the sensitivity to Al,
showed by erythroid cell populations of animals chronically exposed to the metal. In order to investigate whether Al could
also affect human cells, experiments were carried out both on immature and mature human erythroid cells. Erythroid
progenitors (CFU-E, colony-forming units-erythroid) concentrated from human peripheral blood were cultured in an Al-rich
medium under erythropoietin stimulation and their development analysed. Human peripheral erythrocytes were aged in the
presence of Al. Cells were examined using scanning electron microscopy, and membrane proteins analysed by polyacrylamide
gel electrophoresis with sodium dodecyl sulphate and immunoblotting. The development of the Al-treated progenitors was
8750/6600^9200 CFU-E/106 cells, a significantly lower median value (P6 0.05) than that showed by non-treated cells (12 300/
11 200^20 700 CFU-E/106 cells). Erythrocyte morphological changes were induced by Al during the in vitro ageing. The cells
lost their typical biconcave shape, turning into acanthocytes and stomatocytes. Simultaneously, an increased membrane
protein breakdown compatible with band 3 degradation was detected. Besides, Al was found within the cells and attached to
the membrane. The present in vitro results suggest that Al may disturb human erythropoiesis through combined effects on
mature erythrocytes and cellular metabolism in late erythroid progenitors. ß 2002 Elsevier Science B.V. All rights re-
served.
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1. Introduction
Aluminium (Al) loading, as a contributing factor
for the aggravation of the anaemia observed in the
¢nal stage of renal disease, was ¢rst noticed in pa-
tients under dialytic treatment and ingesting Al-con-
taining phosphate binders [1^4]. Considering the
multiple factors a¡ecting erythropoiesis in chronic
renal disease, the use of experimental animals with-
out renal disorder better established the linkage be-
tween Al and the development of anaemia. Regard-
less of the Al compound and the administration
route, anaemia has been induced in rabbits, mice
and rats [5^10]. The in vivo e¡ect of Al showed a
steep reduction in erythroid progenitor cell growth.
Really, this inhibition seemed to be the main early
feature of chronic Al-overloading [8^11].
Another important issue should be considered with
regard to the action of Al on erythropoiesis. The
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deleterious e¡ect of Al could not be restricted merely
to the erythroid progenitors since mature erythro-
cytes might also be a¡ected. The fact that Al induces
changes in red blood cell (RBC) morphology has
been established in Al-overloaded rabbits by the ¢nd-
ing of anisocytosis (abnormal cell size variations) and
poikilocytosis (abnormal cell shape variations) in
blood smears [5]. Similar results were found in rats
chronically treated with Al citrate [10]. Moreover,
electron microscopy analysis of RBCs revealed the
loss of their typical biconcave shapes, and the ap-
pearance of anomalous cells such as leptocytes
(thin and plain), acanthocytes or echinocytes (spicu-
lated) and target cells, strongly suggesting membrane
alterations [10].
Not much information is available regarding the
e¡ects of Al on human erythrocytes. In vitro short-
term assays showed that the highly lipophilic Al ace-
tylacetonate interacts with the membrane of human
erythrocytes, resulting in alterations of their mor-
phology from discoid to both echinocytic and stoma-
tocytic forms [12].
In normal red cells, the biconcave disc shape cre-
ates an advantageous surface area^volume relation-
ship, allowing red cells to undergo marked deforma-
tion while keeping a constant surface area. Directly
or indirectly, membrane integral and skeletal pro-
teins ^ band 3, actin and spectrin ^ as well as pro-
tein^protein interaction play an important role in the
regulation of factors that in£uence cellular deform-
ability [13]. Regarding this subject, one of the aims of
the present investigation was to study the e¡ects of
Al compounds on the morphology of human eryth-
rocytes and on the integrity of their membrane pro-
teins. With this purpose, the ability of Al to modify
human RBCs treated for di¡erent periods was eval-
uated by scanning electron microscopy and immuno-
blotting. Finally, in order to determine the e¡ects of
the metal on immature human erythroid cells, the
development of erythroid progenitors grown in an
Al-rich medium was studied.
2. Materials and methods
2.1. Chemicals
All chemicals used were of analytical grade.
K-Minimum essential medium (K-MEM), 199 me-
dium, penicillin^streptomycin, HEPES bu¡er, bovine
serum albumin (BSA), human apo-transferrin (apo-
Tf), p-nitroblue tetrazolium chloride (NBT), 5-bro-
mo-4-chloro-3-indolyl phosphate p-toluidine salt
(BCIP), 2,7-diamino£uorene (DAF), alkaline phos-
phatase-conjugated antibody to mouse IgG, mono-
clonal anti-human band 3 (clone BIII-136), monoclo-
nal anti-actin (clone AC-40), and monoclonal anti-
spectrin K and L (clone SB-SP1) were purchased
from Sigma, USA. Rainbow molecular weight
marker and Ficoll-Paque Plus were from Amersham
Pharmacia Biotech, Sweden. Silver Stain Kit was
from Bio-Rad, USA. Foetal bovine serum (FBS)
was obtained from Bioser, Nutrientes Celulares
S.A., Argentina, and recombinant human erythro-
poietin (Epo) Pronivel, from Elea S.A.C.I.F. y A.,
Argentina.
Ultrapure water with 18 M6 speci¢c resistivity
(Simplicity 185, Millipore, USA) was employed to
prepare all solutions and media.
2.2. Colony assay of human peripheral erythroid
progenitors
Erythroid progenitor cells concentrated from hu-
man peripheral blood were separated over Ficoll-
Paque Plus (1.077 g/cm3) by centrifugation at
400Ug for 30 min at 25‡C. Interface mononuclear
cells were collected and washed twice with K-MEM
containing 2% FBS. In order to separate adherent
from nonadherent cells, mononuclear cells were sus-
pended in K-MEM containing 50 mg/l gentamicine
sulphate and 30% FBS at a concentration of approx-
imately 5U106 cells/ml. Adherent cells were removed
by an overnight incubation in culture dishes at 37‡C
in a 5% CO2 atmosphere.
Triplicate cultures were carried out in semisolid
medium following the technique described by
Garbossa et al. [14] with modi¢cations. Brie£y,
non-adherent mononuclear cells were plated at a
concentration of 3.5U105/ml in a mixture containing
K-MEM, 0.8% methylcellulose, 25 mM HEPES bu¡-
er, 26 mM NaHCO3, 30% FBS, 2 mM L-glutamine,
0.1 mM 2-mercaptoethanol, 50 mg/l gentamicine
sulphate, 1 WM apo-Tf and 2 IU/ml Epo. Two
parallel series were performed in the presence (Al)
or absence (C) of 100 WM Al citrate. Cultures were
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incubated at 37‡C for 10 days in an atmosphere
containing 5% CO2 and 100% humidity. Small
erythroid colonies consisting of eight or more cells,
with at least two haemoglobinised cells, were
counted as colony-forming units-erythroid (CFU-
E). These colonies were stained with 0.9 mg/ml
DAF, 0.2% H2O2 in 0.2 M Tris^HCl bu¡er, pH
7.0 [15], and counted using an inverted microscope.
Geometric means of triplicates were calculated for
each assay. Cultures without Epo were routinely in-
cluded.
2.3. In vitro erythrocyte ageing
Heparinised human peripheral blood was collected
from laboratory sta¡ members (29^35 years old).
Plasma and bu¡y coat were carefully removed after
10 min centrifugation at 500Ug and 4‡C. RBCs were
harvested after repeated washing in 10 volumes of
isotonic phosphate-bu¡ered saline (0.137 M NaCl,
3 mM KCl, 1.9 mM NaH2PO4, 8.1 mM Na2HPO4,
pH 7.4).
Packed cells were suspended in 199 medium, con-
taining 2 mM L-glutamine, 100 U/ml penicillin, 100
Wg/ml streptomycin, and subjected to in vitro ageing
for di¡erent periods (from 3 to 14 days).
Two parallel assays were run: erythrocytes aged
for ‘t’ days without Al (Ct) and erythrocytes incu-
bated for the same period in the presence of 10 or
100 WM Al concentrations, added as either Al citrate
or Al chloride (Alt).
Medium renewal with or without Al was per-
formed every 2 days. Fresh erythrocytes were also
assayed as control for the ageing process (C0).
2.4. Ghost preparation
The whole procedure was performed at 4‡C. Er-
ythrocytes were haemolysed by diluting 1:10 with
hypotonic 5 mM sodium phosphate bu¡er, pH 8.0,
containing 50 WM phenylmethylsulfonyl £uoride, 50
mg/l soybean trypsin inhibitor, and 1 mg/l aprotinin.
RBC ghosts and supernatant cytosol fractions were
obtained after 30 min centrifugation at 13 000Ug.
Pelleted membranes were repeatedly washed until
creamy white. Ghosts were suspended in the lysis
bu¡er. The suspensions and cytosol fractions were
kept at 320‡C.
2.5. Electrophoresis of membrane proteins
Polyacrylamide gel electrophoresis with sodium
dodecyl sulphate (SDS^PAGE) was carried out em-
ploying the discontinuous bu¡er system of Laemmli
[16]. The monomer concentration (T%) in the slab
mini gels was 4% in the stacking and 8% in the run-
ning gel. Samples were dissociated by mixing them in
SDS sample bu¡er (62.5 mM Tris^HCl, pH 6.8, con-
taining 2% SDS, 5% 2-mercaptoethanol, 10% glycer-
ol and bromophenol blue as tracking dye) and then
boiled for 1 min. Amounts of 5 Wg of protein were
applied in each lane. Protein concentrations had been
previously determined by the method developed by
Lowry et al. [17]. Constant current of 20 mA during
the isotachophoretic process in the stacking gel and
25 mA throughout the running gel were applied; the
whole electrophoretic procedure lasting approxi-
mately 1 h. A molecular weight protein standard
was included in each slab gel. At the end of the
running, a double staining using silver reagent and
Coomassie brilliant blue R-250 (CBB) was developed
according to Dzandu et al. [18]. Gels were ¢rst
stained with Bio-Rad silver kit and then with 0.2%
CBB in 30% methanol/10% acetic acid, allowing a
colour-coded di¡erentiation of proteins.
Gels run in parallel were used for immunoblotting.
2.6. Immunoblot technique
Western blot was carried out following the meth-
odology described by Towbin et al. [19]. Proteins
were electrotransferred to nitrocellulose membranes
for 1.5 h employing transfer bu¡er (25 mM Tris, 195
mM glycine, 0.05% SDS, pH 8.3, 20% (v/v) metha-
nol). Blots were soaked overnight in 2% BSA in TBS
(25 mM Tris, 137 mM NaCl, 3 mM KCl, pH 7.4),
incubated with primary antibodies for 1 h and
washed twice with TBS^0.05% Tween and once
with TBS. Incubation with alkaline phosphatase-con-
jugated antibody to mouse IgG as a secondary anti-
body was performed for 1 h. Unbound proteins were
removed by repeating the above mentioned washing
procedure. Then, BCIP and NBT reagents were used
as substrate and colour developer, respectively.
Monoclonal anti-human band 3, anti-actin, and
anti-spectrin were used as ¢rst antibodies. Appropri-
ate dilutions were carried out in 1% BSA in TBS.
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2.7. Scanning electron microscopy
One drop of each erythrocyte suspension sample
was placed on a 50 mm2 glass support and ¢xed for
20 min by 3% glutardialdehyde in 0.1 M phosphate
bu¡er, pH 7.4. Samples were washed three times with
the phosphate bu¡er, and subsequently dehydrated
by successive washing in graded acetone (from 25
to 100%). The critical drying step was performed in
a Balzers CPD 030 Critical Point Bomb using carbon
dioxide as transition £uid. Samples were coated with
a thin layer of gold-palladium (Balzers Union SCD
040) and examined with a scanning electron micro-
scope (Phillips 515).
2.8. Aluminium content in cellular fractions
In order to avoid Al trace contamination, all the
plasticware used was immersed in 30% HCl for 1^2 h
and then exhaustively rinsed with ultrapure water. Al
levels were measured in erythrocyte fractions, Al
working solutions, culture media and ultrapure water
using an atomic absorption spectrometer (Shimadzu
AA-6501, Japan) coupled to a graphite furnace
atomiser (Shimadzu GFA-6000, Japan) with auto-
sampler.
The Al content, determined in membrane and cy-
tosol fractions after erythrocyte lysis, was expressed
per protein concentration, which was measured by
the Lowry method [17].
2.9. Statistical analysis
The results are expressed either as mean and stan-
dard error or as median and range. Comparisons
between groups were carried out by the non-para-
metric Mann^Whitney U-test, and least signi¢cant
di¡erences with P6 0.05 were considered the criteri-
on of statistical signi¢cance.
3. Results
3.1. E¡ect of Al on erythroid progenitor
cell development
In order to elucidate if Al has any e¡ect on ery-
throid di¡erentiation of human immature cells, ery-
throid progenitors concentrated from peripheral
blood were cultured in the presence or absence of
Al citrate under Epo stimulation. As can be seen in
Fig. 1, the addition of Al to the culture medium
induced a signi¢cant 30% decrease in the develop-
ment of erythroid colonies with respect to controls.
Results of ¢ve assays expressed as median/range,
were C: 12 300/11 200^20 700 and Al: 8750/6600^
9200 CFU-E/106 cells (P6 0.05). Box plots represent
interquartile range, including data between 25th and
75th percentiles. Vertical bars indicate the minimum
and maximum values.
3.2. Changes in cell morphology
The e¡ect of Al on cell morphology was studied by
scanning electron microscopy of erythrocytes that
had been incubated in the presence of either Al cit-
rate or Al chloride for 14 days. The ageing process
slightly a¡ected the erythrocyte shape. Except for a
few crenated cells, none of the samples aged without
Al showed altered cells (Fig. 2a). On the other hand,
erythrocytes incubated with Al showed many abnor-
mal shapes (Fig. 2b^f). The typical erythrocyte bi-
concave shape turned into acanthocytic (Fig. 2c,e)
Fig. 1. E¡ect of Al on erythroid progenitor cell development.
Human erythroid progenitors concentrated from peripheral
blood were stimulated in vitro by Epo, and cultured in the
presence (Al) or absence (C) of 100 WM Al citrate for 10 days.
The ¢gure shows the signi¢cant 30% decrease of the CFU-E
number with respect to controls when erythroid progenitor cells
were grown in contact with Al (n = 5, P6 0.05).
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and stomatocytic (Fig. 2b,c,f) shapes. The former,
also named echinocyte or crenated cell, is a spicu-
lated cell, while the latter, a cup-shaped cell, displays
one important cavity. Both acanthocytes and stoma-
tocytes seem to be the predominant erythrocyte
shapes induced by the presence of Al.
These e¡ects produced by Al on RBCs were de-
tected even at low concentrations. Approximately
20^30% of acanthocytes and stomatocytes developed
from erythrocytes aged in the presence of 10 WM Al
compounds (data not shown).
3.3. Electrophoresis and immunoblotting
A close relationship can be established between
membrane organisation and cell shape. Taking into
Fig. 3. Pro¢les of proteins from control and Al-treated RBC membranes. Human erythrocyte membrane proteins were analysed by
SDS^PAGE and immunoblot with antibody to band 3. The ghost proteins were obtained from: fresh RBCs (C0), RBCs incubated for
3 (C3), 7 (C7) and 14 (C14) days, and RBCs incubated in the presence of 100 WM Al chloride for 3 (Al3), 7 (Al7) and 14 (Al14) days.
Patterns of band 3 protein from erythrocytes aged in the presence of Al show a decreased concentration of the complete molecule of
band 3 (MrW95 000) and increased amounts of band 3 fragments of lower Mr (W40 000). Studies performed at 3, 7 and 14 days sug-
gest a time-related increasing of band 3 degradation products.
Fig. 2. Scanning electron microscopy of human erythrocytes aged in vitro for 14 days in the absence (a) or presence (b^f) of Al.
(a) General aspect of a control sample of aged erythrocytes (1200U). (b) General aspect of Al-treated erythrocytes showing the loss
of their normal shape and the presence of stomatocytes (2620U). (c) Stomatocytic and crenated shapes after cells were incubated with
Al (4400U). (d) Di¡erent abnormal shapes induced by Al (5000U). (e) Details of an acanthocyte (10 000U) and (f) a stomatocyte
(10 000U).
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account the induction of altered erythrocyte shapes
due to Al, the following step was to analyse mem-
brane proteins from erythrocyte ghosts.
Membranes obtained from RBCs incubated with
Al for 3, 7, or 14 days were solubilised and analysed
by SDS^PAGE. The protein patterns in the double-
stained (silver plus CBB) gels showed hardly any
di¡erence between samples aged in the presence or
absence of Al.
In order to detect individual proteins and
their possible minor fractions, an immunoblotting
technique employing monoclonal antibodies to
band 3, spectrin, and actin was applied in parallel
gels.
Figure 3 shows the characteristic immunoblots of
membrane proteins from controls and Al-treated er-
ythrocytes that have been developed with anti-hu-
man band 3 antibody. It can be noticed that this
antibody normally recognises band 3 protein of rel-
ative molecular mass MrW95 000 and several pep-
tides of lower Mr, migrating in the regions of
MrW60 000, 40 000 and 20 000. After the ageing of
human erythrocytes in an Al-rich medium, immuno-
blot analysis showed altered patterns of band 3 mem-
brane protein (Fig. 3, Al lanes) when compared to
the corresponding control (Fig. 3, C lanes). An in-
creased concentration of fragments of lower Mr, par-
ticularly the one of 40 000, with diminution of the
complete molecule (95 000 fraction) is compatible
with a band 3 degradation pattern. The increase of
protein degradation along the incubation time, par-
ticularly observed at 7 and 14 days, suggests a time-
related toxic e¡ect of Al. This pattern describing
protein breakdown was specially related to band 3,
while no signi¢cant changes were observed in immu-
noblots obtained with antibodies against the proteins
actin and spectrin.
3.4. Control assays
Control assays performed in the presence of 100
WM sodium citrate instead of Al citrate showed no
changes in the morphology and membrane proteins
of the RBCs, suggesting that the alterations observed
can not be attributed to osmolarity variations due to
Al addition. Moreover, no changes in the pH of the
incubation medium were registered throughout ex-
perimental periods.
The alterations mentioned above were unrelated to
the Al compound used, either chloride or citrate.
3.5. Aluminium concentration in cell membrane and
cytosol fractions
In order to ¢nd out whether Al was able to enter
the cell under the experimental conditions employed
Fig. 4. Al content in erythrocyte fractions. RBCs were aged
without Al (control) or in the presence of 10 and 100 WM Al
chloride for 3 or 7 days. Al content was measured after RBC
lysis in (a) membrane and (b) cytosol fractions. These data are
plotted vs. Al concentration in the incubation medium. Each
point represents mean þ standard error of three assays. Al en-
ters the cell (b) and signi¢cantly high Al amounts (P6 0.01) are
found attached to the membrane after long-term incubation
with the highest Al dose (a). No signi¢cant di¡erences were
found when comparing intracellular Al content with either Al
doses or incubation time (b).
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and, eventually, to study metal distribution within
the cell, Al concentrations were determined in mem-
brane (Fig. 4a) and cytosol (Fig. 4b) fractions after
erythrocyte lysis. RBCs were incubated in the pres-
ence of either 10 or 100 WM Al chloride for 3 and
7 days. Figure 4 shows that Al does enter the cell as
it was found in the cytosol fraction (Fig. 4b). Where-
as no di¡erences could be observed in the intracellu-
lar content in relation to either the duration of the
incubation period or the metal dose (Fig. 4b), high
amounts of Al were found attached to the membrane
after 7-day incubation with 100 WM Al (Fig. 4a).
This result was signi¢cantly di¡erent (P6 0.01)
from those observed with lower Al doses and
through short-term incubation.
The Al content in control fractions which had
been incubated throughout the time of the experi-
ments without addition of Al is shown in Fig. 4 at
the abscissa value x = 0.
4. Discussion
This work shows that human erythroid cells are
a¡ected by Al, suggesting that these cells are as sen-
sitive to Al as those from animals and cellular lines.
The 30% decrease of human CFU-E growth ob-
served in cultures developed in the presence of Al
(Fig. 1) is in close agreement with the CFU-E inhi-
bition detected when testing bone marrow cells from
Al-overloaded animals [8^10]. The fact that the e¡ect
observed in these progenitor cells is a depressed re-
sponse to Epo suggests that the inhibitory e¡ect in-
duced by Al might involve the interaction of the
hormone with its target cell. Indeed, we have dem-
onstrated that the in vitro inhibitory process induced
by Al on mice CFU-E growth was closely related to
the presence of Epo, occurred only at early stages of
the di¡erentiation process induced by the hormone,
and could not be reversed by increasing doses of Epo
[14].
The present experimental design focused attention
on mechanisms by which Al might a¡ect the eryth-
ropoietic system, hence the e¡ects were achieved
under high Al exposure.
The alteration of erythrocyte morphology in
chronically Al-overloaded rats triggers some ques-
tions: Do altered erythroid progenitor cells turn
into abnormal erythrocytes? Or, on the other hand,
are mature RBCs a¡ected by direct contact with Al
in the blood stream during their life span? In order
to further clarify this subject, we evaluated the in
vitro e¡ects of Al on peripheral erythrocytes by
studying not only their morphology but also their
membrane components. The results obtained let us
assume that Al does a¡ect human erythrocytes in a
way that resembles the toxic e¡ects induced in rats
by the ingestion of Al [10]. The incubation of eryth-
rocytes with Al was e¡ective to induce changes in
their typical morphology, turning them into acantho-
cytes and stomatocytes (Fig. 2). This observation is
in agreement with similar previous ¢ndings detected
in human [12] and animal [5,10,20] RBCs under the
e¡ects of Al.
Certain RBC membrane disorders resulting in the
development of abnormal shapes and altered geom-
etry of erythrocytes involve unusual interactions
among membrane components. Moreover, several
band 3 variants have been associated with acantho-
cytosis. In the RBC membrane, the bilayer of amphi-
philic lipid is anchored to a network of skeletal pro-
teins through transmembrane proteins. Band 3, the
major integral membrane protein, interacts with the
erythrocyte membrane skeleton that mainly includes
spectrin, actin, ankyrin and protein 4.1. The organ-
isation of this particular protein network in the inner
surface of the plasma membrane is responsible for
maintaining the shape, stability and deformability
of erythrocytes [21]. In this work, Al induced mem-
brane protein changes that seem to be restricted to
band 3. After the ageing of human erythrocytes in an
Al-rich medium, the immunoblot analysis demon-
strated an altered membrane protein pattern compat-
ible with band 3 degradation. A decreased concen-
tration of complete band 3 molecule and increased
concentration of band 3 fragments of lower Mr ap-
pear to be directly related to the duration of the
incubation period with Al (Fig. 3). It has been pro-
posed that degradation of band 3 protein is involved
in the generation of a senescence signal of erythro-
cytes that leads to the recognition and removal of old
erythrocytes from the circulation [22]. The exact
mechanism of this in vivo protein degradation during
erythrocyte ageing has not been clari¢ed yet, but
degradation of band 3 by calpain is known to be
increased in RBC membranes of old people as com-
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pared with those of young people [23]. Since en-
hanced calpain activity was found in cerebral cortex
of rats following Al exposure [24], a protease-medi-
ated mechanism might be also postulated for the
action of Al upon RBC membrane. This mechanism
would not exclude the possibility of an e¡ect of Al
on the arrangement of the lipidic bilayer as it has
been suggested that the bilayer of normal RBC mem-
brane is stabilised by band 3 interactions with mem-
brane lipids [25]. Therefore, according to the bilayer
hypothesis in erythrocytes, shape changes induced by
foreign molecules may be due to di¡erential expan-
sion of their two monolayers. Spiculated shapes
(echinocytes or acanthocytes) may arise when the
added compound accumulates in the outer mono-
layer, whereas cup shapes (stomatocytes) would be
observed when the compound is inserted in the inner
monolayer [26]. The fact that Al induces both acan-
thocytes and stomatocytes, such as it was found in
this work and in the study by Suwalsky et al. [12],
probably indicates that the metal interacts with both
the outer and the inner monolayers of the erythro-
cyte membrane. Even though no speci¢c Al location
could be established in the two halves of the bilayer,
it is clear that the metal enters the cell and attaches
in high amounts to the membrane (Fig. 4). This last
observation strongly supports a hypothesis of the
formation of membrane gaps due to Al with subse-
quent membrane re-arrangements [27].
In view of the present in vitro assays, it would be
right to assume that RBCs are sensitive to the action
of Al. Nevertheless, this would not be an exclusive
e¡ect since altered mature erythrocytes might, alter-
natively, be derived from abnormal progenitors.
Therefore, these results suggest that Al may disturb
human erythropoiesis through combined e¡ects on
mature erythrocytes and cellular metabolism in late
erythroid progenitors.
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